Institutional Investors Are Buying Henry Schein Inc (NASDAQ:HSIC)

Henry Schein, Inc. (NASDAQ:HSIC) Logo

Sentiment for Henry Schein Inc (NASDAQ:HSIC)

Henry Schein Inc (NASDAQ:HSIC) institutional sentiment increased to 1 in Q3 2018. Its up 0.23, from 0.77 in 2018Q2. The ratio has improved, as 192 active investment managers increased or started new positions, while 192 cut down and sold stakes in Henry Schein Inc. The active investment managers in our partner’s database now hold: 153.30 million shares, down from 162.48 million shares in 2018Q2. Also, the number of active investment managers holding Henry Schein Inc in their top 10 positions increased from 6 to 9 for an increase of 3. Sold All: 22 Reduced: 170 Increased: 123 New Position: 69.

Henry Schein, Inc. provides health care services and products to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. The company has market cap of $11.36 billion. It operates through two divisions, Health Care Distribution, and Technology and Value-Added Services. It has a 29.12 P/E ratio. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair services.

The stock increased 0.99% or $0.73 during the last trading session, reaching $74.5. About 1.98M shares traded or 28.80% up from the average. Henry Schein, Inc. (NASDAQ:HSIC) has risen 26.61% since January 5, 2018 and is uptrending. It has outperformed by 26.61% the S&P500.

Analysts await Henry Schein, Inc. (NASDAQ:HSIC) to report earnings on February, 19. They expect $1.11 earnings per share, up 14.43 % or $0.14 from last year’s $0.97 per share. HSIC’s profit will be $169.21 million for 16.78 P/E if the $1.11 EPS becomes a reality. After $1.03 actual earnings per share reported by Henry Schein, Inc. for the previous quarter, Wall Street now forecasts 7.77 % EPS growth.

Generation Investment Management Llp holds 9.2% of its portfolio in Henry Schein, Inc. for 13.56 million shares. Black Creek Investment Management Inc. owns 2.60 million shares or 6.73% of their US portfolio. Moreover, Longview Partners (Guernsey) Ltd has 5.73% invested in the company for 13.65 million shares. The Illinois-based Zuckerman Investment Group Llc has invested 4.23% in the stock. Hoplite Capital Management L.P., a New York-based fund reported 328,932 shares.

Since January 1, 0001, it had 0 insider purchases, and 3 insider sales for $8.60 million activity.

Henry Schein, Inc. (NASDAQ:HSIC) Ratings Coverage

Ratings analysis reveals 0 of Henry Schein’s analysts are positive. Out of 5 Wall Street analysts rating Henry Schein, 0 give it “Buy”, 3 “Sell” rating, while 2 recommend “Hold”. The lowest target is $66 while the high is $90. The stock’s average target of $79 is 6.04% above today’s ($74.5) share price. HSIC was included in 6 notes of analysts from August 7, 2018. The rating was maintained by Stifel Nicolaus with “Hold” on Tuesday, August 7. The stock has “Underperform” rating by Evercore on Thursday, January 3. The rating was downgraded by Edward Jones on Thursday, October 25 to “Sell”. The rating was maintained by Morgan Stanley on Tuesday, October 9 with “Underweight”. Robert W. Baird downgraded the stock to “Neutral” rating in Wednesday, January 2 report. Robert W. Baird maintained Henry Schein, Inc. (NASDAQ:HSIC) rating on Tuesday, August 7. Robert W. Baird has “Outperform” rating and $90 target.

More notable recent Henry Schein, Inc. (NASDAQ:HSIC) news were published by: Seekingalpha.com which released: “Premarket analyst action – healthcare – Seeking Alpha” on October 19, 2018, also Nasdaq.com with their article: “Henry Schein (HSIC) Q4 Earnings in Line, Revenues Beat – Nasdaq” published on February 20, 2018, Nasdaq.com published: “Report: Exploring Fundamental Drivers Behind Cronos Group, Henry Schein, Argo Group International, Eiger BioPharmaceuticals, China Automotive, and Moleculin Biotech — New Horizons, Emerging Trends, and Upcoming Developments – Nasdaq” on December 31, 2018. More interesting news about Henry Schein, Inc. (NASDAQ:HSIC) were released by: Seekingalpha.com and their article: “Why We Believe Henry Schein’s Upcoming Animal Health Spin-Off Will Unlock 30% To 50% Upside – Seeking Alpha” published on September 26, 2018 as well as Nasdaq.com‘s news article titled: “Pre-Market Earnings Report for August 6, 2018 : SRE, TSN, CAH, NWL, HSIC, VST, JEC, CFX, KOS, BID, IRWD, SEAS – Nasdaq” with publication date: August 03, 2018.

Henry Schein, Inc. (NASDAQ:HSIC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.